Opposition to Price Controls for Medicare Part B Drugs

In a letter to the Department of Health and Human Services, ATR and 56 other conservative groups and activists expressed opposition to HHS's “International Pricing Index” (IPI) payment model for drugs administered under Medicare Part B.



Comment
Show comments Hide Comments


Related Articles